Temasek Holdings

Temasek Holdings is an investment company based in Singapore, founded in 1974, with a diverse portfolio valued at approximately S$242 billion. The firm invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, agriculture, and energy. Temasek's investment strategy is guided by long-term trends, focusing on themes such as transforming economies, rising middle-income populations, and emerging champions. Its investment structure includes a mix of liquid assets, listed and unlisted holdings, and private equity, reflecting a commitment to being a significant shareholder in both local and international businesses. Temasek Capital Management, a subsidiary, specializes in private equity and mid-stage technology and life sciences investments, further enhancing Temasek's global investment footprint.

John Marren

Senior Managing Director

Lim Ming Pey

Associate Director

Past deals in Growth Stage

Amogy

Series B in 2023
Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Ionblox

Series B in 2023
Zenlabs has developed proprietary silicon-based formulations that offer higher specific capacity, longer cycle life, and lower cost. Zenlabs' anodes are unique in their high loading level and high active silicon content. In addition, Zenlabs has solved the common problems with silicon based anodes such as poor cycling and swelling. Zenlabs combines these high capacity anodes with high capacity cathode materials in large format pouch cells to achieve energy densities that are much higher than what is commercially available.

Pasqal

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

DotPe

Series B in 2022
DotPe is a commerce and payments platform seeking to disrupt the payment experience by increasing customer engagement and offering catalog discovery. The technology start-up provides an offline enterprise business with a commerce and payments platform to drive digital transformation in the way they sell, manage, and engage their customers. It enables businesses to sell more, sell directly, and sell more efficiently. It was founded in 2019 by Anurag Gupta, Gyanesh Sharma, and Shailaz Nag, and its headquarters are located in Gurgaon, Haryana, India.

OnPoint

Series B in 2022
OnPoint is delivering secure IT infrastructure, enterprise systems and solutions for the U.S. federal government.

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company specializing in cloud computing and data processing solutions for data centers. Founded by Dr. Sunny Siu in 2020, the company develops data processing unit (DPU) chips aimed at enhancing the efficiency of data processing for its clients. Jaguar Microsystems offers products that feature accelerated Remote Direct Memory Access (RDMA) and RoCE, specifically designed for data center applications. The company targets domestic cloud service providers, telecommunications, and Internet service providers while also expanding its reach to meet the demands of the global market.

TeraWatt Technology

Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, with a subsidiary in Tokyo, Japan, specializes in the design and development of lithium-ion rechargeable batteries. The company's focus is on creating batteries that combine high energy density, power density, and safety, catering to various electrified applications. By leveraging advanced engineering and production techniques, TeraWatt Technology aims to provide industrial clients with long-lasting, safe, and reliable power solutions, thereby enhancing the performance of their electrified systems.

Brightseed

Series B in 2022
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

UPSIDE Foods

Series C in 2022
Memphis Meats develops meat produced directly from animal cells without the need to raise and slaughter actual animals that require significantly less caloric input, water, land, and energy than conventional meat production, enabling consumers to enjoy meat products that are clean and free from harmful chemicals. Founded by Uma Valeti and Nicholas Genovese in 2015, Memphis Meats is headquartered in San Francisco, California.

waresix

Series B in 2022
Waresix is a logistics platform for freight-forwarding, warehouse, and land transportation. It is a platform that matches unused warehouse space with users in need of such facility, looks to capitalize on the demand for flexible warehousing given the booming e-commerce market in the country. Waresix provides a solution for dynamic warehousing strategy that allows customers, retailer, distributor, and manufacturer to quickly adapt to variable demand. Waresix is headquartered in Jakarta, Indonesia.

Autobrains

Series C in 2022
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Immutable

Series C in 2022
Immutable Pty Ltd, founded in 2018 and based in Sydney, Australia, specializes in developing video games that leverage blockchain technology. The company focuses on creating scalable infrastructure that enhances in-game economies, promoting transparency and enabling player ownership of in-game assets. Immutable provides tools and services that allow players the freedom to trade and build their gaming experiences. Originally known as Fuel Games Pty Ltd, the company emphasizes empowering players by returning control over digital assets to them.

Wildtype

Series B in 2022
Wild Type, Inc. is a San Francisco-based company that produces meat, poultry, and seafood through cellular agriculture, eliminating the need for raising or slaughtering animals. Founded in 2016, Wild Type offers a sustainable alternative to traditional food sources, addressing critical issues such as climate change, food security, and public health. By leveraging advanced cellular agriculture technologies, the company aims to redefine how society sources healthy and delicious meat, contributing to a more sustainable food ecosystem.

AMBER AI

Series B in 2022
Amber Group is a prominent cryptocurrency financial services provider based in Hong Kong, established in 2017 by finance professionals with backgrounds in major institutions. The company offers a range of services, including cryptocurrency trading, yield enhancement, collateralized lending, decentralized finance, and electronic market making. With a global presence that includes locations in Taipei, Seoul, and Vancouver, Amber Group operates continuously to serve over 200 institutional clients, facilitating trading across more than 60 electronic exchanges. The firm has cumulatively traded over $200 billion, maintaining an average daily trading volume between $100 million and $200 million. Amber Group emphasizes the integration of advanced technology with quantitative research to enhance investment flexibility, maximize returns, and deliver sustained value to its clients.

Soul Machines

Series B in 2022
Soul Machines Limited develops emotionally responsive avatars that augment and enrich the user experience for artificial intelligence (AI) platforms. The company’s products include Digital DNA Studio, which allows user to build custom digital people for customer care, sales and marketing, brand and influencer, product, wellbeing, people and performance, training and education, and digital innovation purposes. The company was incorporated in 2016 and is headquartered in Auckland, New Zealand with additional offices in San Francisco and Los Angeles, California; New York, New York; London, United Kingdom; Tokyo, Japan; and Melbourne, Australia.

Waterdrop

Series B in 2022
Waterdrop is a producer of innovative water-based beverages designed to enhance hydration and wellness. The company offers a unique product in the form of small, sugar-free, dissolvable cubes that transform plain water into flavorful drinks. These micro drinks are enriched with vitamins and extracts sourced from high-quality natural ingredients, including fruits and plants. This approach allows consumers to enjoy a refreshing beverage without added sugars while promoting adequate hydration. Waterdrop emphasizes the use of environmentally friendly raw materials, aligning its products with sustainable practices.

FTX

Series C in 2022
FTX Trading LTD operates a cryptocurrency derivatives exchange and trading platform for traders and investment professionals. Its platform offers futures trading, leveraged tokens, and an OTC portal. The company’s platform supports quarterly and perpetual futures on various cryptocurrencies and altcoins, such as bitcoin, ether, binance coin, and tether, as well as various altcoin, midcap, and other indices. The company was founded in 2017 and is based in San Francisco, California.

H2Pro

Series B in 2022
H2Pro, Ltd. is a company that specializes in innovative water-splitting technology aimed at producing hydrogen fuel. Founded in 2019 and based in Caesarea, Israel, H2Pro has developed a proprietary electrolysis method known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting). This technology effectively separates the hydrogen and oxygen evolution reactions, offering a super-efficient approach to green hydrogen production.

eFishery

Series C in 2022
eFishery is automatic fish feeder for all types of fish. This tool can not only provide feed scheduled, with a dose efficient, and automatic, but also record every feed in real-time. You can access the data feed, anytime, anywhere with precision. There is no longer a problem of over-feeding, fish feeding or feed irregularly diverted. eFishery provide the best solutions, reliable, and affordable.

Ola Electric

Series C in 2021
Ola Electric Mobility Pvt Limited, founded in 2017 and headquartered in Bengaluru, India, is a prominent player in the electric vehicle sector. As a subsidiary of ANI Technologies Private Limited, the company specializes in the manufacturing of electric vehicles and key components, such as battery packs, motors, and vehicle frames, at its Ola Futurefactory. Ola Electric aims to enhance electric mobility by collaborating with vehicle and battery manufacturers, cities, and driver-partners to create a comprehensive and affordable mobility ecosystem. The company not only focuses on the domestic market but is also exploring opportunities for exporting its electric vehicles to select international markets, positioning itself to capitalize on the growing demand for sustainable transportation solutions in India and beyond.

Clara Foods Co.

Series C in 2021
Clara Foods Co. specializes in producing animal-free proteins and ingredients for the food and beverage industry. Founded in 2014 and based in South San Francisco, California, the company utilizes advanced fermentation techniques to create functional and nutritional proteins derived from microorganisms. This innovative approach allows Clara Foods to offer a sustainable alternative to traditional animal agriculture, focusing on products such as baking ingredients, nutritional supplements, and egg white substitutes that are free from pathogens and salmonella. Their egg white products are particularly suited for baking applications, including cakes, meringues, and macarons. Clara Foods aims to transform the food industry by providing healthier and more humane protein sources.

Wenext

Series B in 2021
Founded in 2014, Wenext has since produced more than 15 million parts. With our large and efficient digital production facilities and systems, we could produce high-quality parts; reduce operation cost and production time, as short as 1 day. ISO 9001 certified.

Commonwealth Fusion

Series B in 2021
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

Carro

Series C in 2021
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

RWDC Industries

Series B in 2021
RWDC Industries Ltd develops and manufactures medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. It develops polyhydroxyalkanoate (PHA) emulsion coating, a water-based PHA emulsion for paper and paperboard that can replace polyethylene (PE) in plastic-lined food packaging and thermoplastic replacement technologies, which allows for direct drop-in-replacement for existing petroleum based plastic items such as polypropylene straws, polystyrene containers, coffee cups and lids, utensils, fibers and polyethylene bags. The company was founded in 2015 and is based in Singapore.

SaladStop!

Series B in 2021
SaladStop! is a pioneer in the healthy food movement in Singapore and aims to serve the best tasting and most nutritious salads, wraps and grain bowls. SaladStop! currently operates 23 outlets in Singapore and Manila and quickly approaching their vision of becoming the world’s leading nutrition, health and wellness company, expanding to Indonesia and Japan later this year.

Arbor Biotechnologies

Series B in 2021
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.

Autobrains

Series C in 2021
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Autobrains

Series C in 2021
Cartica’s revolutionary automotive visual intelligence platform is built on the foundation of a mature self-learning technology backed by more than 200 patents. Utilizing robust signature-based representation structures coupled with unsupervised learning methodologies, Cartica’s visual intelligence platform garners a comprehensive and detailed understanding of the vehicle’s environment.

Memed

Series C in 2021
Memed SA, founded in 2012 and based in Brazil, operates an online platform that provides e-prescription services and social collaboration tools for healthcare professionals. The platform enables doctors to create and manage digital prescriptions, facilitating effective treatment and improving patient adherence to prescribed medications. By connecting healthcare providers with key partners in the industry, Memed enhances the prescription process and supports communication among doctors, ultimately aiming to improve patient care and outcomes.

Fabric

Series C in 2021
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

FTX

Series B in 2021
FTX Trading LTD operates a cryptocurrency derivatives exchange and trading platform for traders and investment professionals. Its platform offers futures trading, leveraged tokens, and an OTC portal. The company’s platform supports quarterly and perpetual futures on various cryptocurrencies and altcoins, such as bitcoin, ether, binance coin, and tether, as well as various altcoin, midcap, and other indices. The company was founded in 2017 and is based in San Francisco, California.

Orca Security

Series C in 2021
Orca Security Ltd. is a company that specializes in cloud-native security solutions, providing a platform that secures both cloud-native and legacy applications migrated to the cloud. Founded in 2019 and based in Tel Aviv, Israel, Orca's technology integrates directly into the cloud infrastructure layer, allowing for comprehensive security assessments of various assets, including the cloud control plane, operating systems, applications, and business data. The platform delivers visibility into compromised resources, vulnerable software, and misconfigurations without the need for agents, thus maintaining performance and availability. By offering cloud-wide, workload-deep security and compliance across major cloud providers like AWS, Azure, and Google Cloud, Orca Security helps organizations identify critical vulnerabilities and attack vectors efficiently, minimizing the operational costs and alert fatigue associated with traditional security tools.

Momenta

Corporate Round in 2021
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offers multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of some of the world’s top experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. Momenta is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.

Allay Therapeutics

Series C in 2021
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.

Open

Series C in 2021
Open develops and offers an online platform for banking and intercompany settlement. It offers digital banking service for startups and small and medium enterprises that offer digital bank accounts that includes a current account packed with tools for bookkeeping, invoices, moving money, and accessing credit. Open's application programming interface platform lets financial institutions integrate banking and payments into their applications and accounting systems. Anish Achuthan founded it in 2017, with its headquarters in Bengaluru in India.

Oviva

Series C in 2021
Oviva AG is a digital health company that specializes in providing medical nutritional counseling services in Switzerland, Germany, and the United Kingdom. Established in 2013 and based in Ingenbohl, Switzerland, the company offers treatment for various medical conditions, including obesity, diabetes, heart disease, and digestive disorders, through both in-person consultations in clinics and remote support. Oviva UK Limited, founded in 2015 and headquartered in London, focuses on digitally-enabled behavior change programs for diet and lifestyle-related health issues. The company has developed a smartphone application that enables clients to communicate with dietitians, maintain a photo food diary, monitor their health goals, and access personalized educational materials. This technology-enabled approach aims to improve health outcomes for patients while reducing healthcare costs by minimizing the need for in-clinic visits and preventing complications associated with chronic conditions.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Innovusion

Series B in 2021
Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes our products the ideal choice for the most demanding applications. We are venture-backed and headquartered in the heart of Silicon Valley.

iCapital Network

Series C in 2021
iCapital Network is an online platform that unlatches the world of private equity, enabling institutions and qualified investors. It is a financial services company that features a financial technology platform that provides modular alternative investment solutions for registered investment advisors, broker-dealers, private banks, family offices, and other sophisticated investors. The company connects advisors and their high net worth investors in leading alternative investment managers through best-in-class user experience. The company was founded in 2013 and headquartered in New York, United States.

Covariant

Series C in 2021
Covariant is a developer of artificial intelligence for robotics. Covariant is building the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them.

Woebot Health

Series B in 2021
Woebot Health is a San Francisco-based company founded in 2017 that specializes in developing mental health chatbot applications. Its primary mission is to make mental health care widely accessible through innovative technology. The company's chatbot engages users in conversation, providing tailored responses to help reduce symptoms of mood-based disorders. By combining effective therapeutic techniques with advanced digital tools, Woebot Health offers a suite of digital therapeutics and behavioral health products designed to be responsive and targeted to individual needs. The company has received funding from several venture capital firms, including New Enterprise Associates, Jazz Venture Partners, and Social Discovery Ventures, as well as contributions from Andrew Ng's AI Fund.

Soldo

Series C in 2021
Soldo Limited is a provider of expense management software solutions tailored for small businesses, enterprises, and accountants. Established in 2014 and based in London, with additional offices in Italy and Ireland, Soldo offers various products, including Soldo Pro, which manages expenses from payment to reconciliation, Soldo Premium for controlling business spending, and Soldo Enterprise for supporting financial strategies. The platform integrates prepaid Mastercard® cards, a web-based administration console, and a mobile app, offering a comprehensive solution to streamline the business expense cycle. This system enhances visibility and control over company spending while automating tasks and ensuring compatibility with major accounting software. Soldo has garnered significant investment, exceeding $80 million, from notable investors, reflecting its commitment to innovation in the fragmented landscape of business spending management.

FTX

Series B in 2021
FTX Trading LTD operates a cryptocurrency derivatives exchange and trading platform for traders and investment professionals. Its platform offers futures trading, leveraged tokens, and an OTC portal. The company’s platform supports quarterly and perpetual futures on various cryptocurrencies and altcoins, such as bitcoin, ether, binance coin, and tether, as well as various altcoin, midcap, and other indices. The company was founded in 2017 and is based in San Francisco, California.

Fortera

Series B in 2021
Fortera develops a process for recreating the natural material that provides significant economic savings. It Founded in 2017 and is based in Campbell, California.

Helix

Series C in 2021
Helix is a prominent population genomics company that operates at the intersection of clinical care, research, and data analytics. The company provides an end-to-end platform designed to facilitate genomic research and the incorporation of genomic data into healthcare practices. Helix operates one of the largest CLIA/CAP-certified next-generation sequencing laboratories and utilizes its proprietary Exome+™ assay to support various aspects of population genomics. These include recruitment and engagement, clinically actionable disease screening, and the return of results. Additionally, Helix engages in large-scale genetic analysis and viral surveillance, delivering actionable genetic insights that aid health systems, life sciences companies, payers, and government entities in enhancing patient care and informing public health decisions.

Bowery Farming

Series C in 2021
Bowery Farming Inc., a farming company, provides post-organic produce. The company offers baby kale, blend, lettuce, arugula, kale mix, and basil products. It sells its products through grocery stores and restaurants. The company was founded in 2014 and is based in New York, New York.

Einride

Series B in 2021
Einride AB is a freight mobility company that specializes in the transportation of goods using innovative technologies. Founded in 2016 and headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, Einride focuses on developing electric and autonomous logistics solutions. The company's flagship products include Einride Pods, which are electric trucks designed for transporting a variety of cargo, including pallets, timber, and perishable goods. Einride also provides clients with tools to plan, order, and track sustainable transport, aiming to redefine logistics through intelligent freight mobility solutions.

Oura

Series C in 2021
Oura is a pioneering sleep performance platform, focused on improving sleep that leads to a better life. The Oura Ring and app gives users daily feedback to improve their health, allowing users to better understand their body and reach their goals. Oura Health OyLtd. is a health technology company founded in Oulu, Finland in 2013. In 2018, the company received the Red Dot Awards for communications design and product design. Backed by world-class investors, leaders, champions, and creators, Oura Health is based in Oulu & Helsinki, Finland, and San Francisco, California.

Abiochem Biotechnology

Series C in 2021
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products, pesticides, etc., and has contributed to the promotion and development of green chemistry.

EAVISION

Series C in 2021
EAVISION is a smart hardware company focusing on the development and manufacturing of autonomous drones for agricultural applications. The company specializes in industrial and fully autonomous agricultural drones that leverage artificial intelligence, autonomous driving, and machine vision technologies. These innovations enable the automation of plant protection operations, such as pesticide spraying and fertilization, thereby improving efficiency and safety for agricultural businesses. Additionally, EAVISION offers advanced capabilities in binocular visual perception, AI autonomous control, and intelligent machine equipment, along with a commercial corn emasculation test system. The company also manages a venture capital fund aimed at investing in innovative projects within China.

Halodoc

Series C in 2021
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, facilitating real-time online consultations. The platform also allows patients to order laboratory tests that can be conducted at home and helps them locate nearby hospitals and clinics. Additionally, HaloDoc provides access to licensed medical laboratory services and a medical delivery service known as ApotikAntar, further enhancing the convenience and accessibility of healthcare for its users.

Hazel Technologies

Series C in 2021
Hazel Technologies, Inc. designs and manufactures packaging inserts to reduce the spoilage of fruits and vegetables. It offers packaging inserts called sachets that are placed in boxes of the produce by growers at the time of harvest, extending the shelf-life of produce by slowing aging in produce and preventing fungus or decay. The company also provides agricultural and horticultural consulting services. Hazel Technologies, Inc. was founded in 2015 and is based in Chicago, Illinois with an additional location in Salinas, California.

Genki Forest

Venture Round in 2021
Genki Forest is a beverage company with Internet genes which specializes in making sugar-free and low-calorie products.

NewMed Medical

Series C in 2021
NewMed Medical Co., Ltd. engages in the research, development, manufacture, and marketing of interventional artificial heart valve systems. Its products include artificial heart valves and transcather implantation systems. The company was founded in 2015 and is based in Shanghai, China.

Tezign

Series C in 2021
Tezign (Beijing) Information Technology Co., Ltd. operates Tezign.com, an Internet platform in China that provides design, creativity, marketing, and experience need services. It offers market and design services, including web/app design, graphic design, illustration, photography, creative strategy, brand strategy, e-commerce solution, event planning, and AR and VR. Tezign (Beijing) Information Technology Co., Ltd. was founded in 2014 and is based in Shanghai, China.

Insitro

Series C in 2021
Insitro is a operator of a data-driven drug discovery and development company that uses machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from Bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via a novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics.

Innovusion

Series B in 2021
Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes our products the ideal choice for the most demanding applications. We are venture-backed and headquartered in the heart of Silicon Valley.

Manner

Series B in 2021
Manner is a specialty coffee chain based in Shanghai, China, founded in 2015. The company operates coffee shops across multiple cities, including Shenzhen, Beijing, Chengdu, and Suzhou, offering a variety of beverages such as coffee, tea, smoothies, juices, and desserts. Manner emphasizes making quality coffee accessible and affordable to all customers while also committing to environmental sustainability. To promote eco-friendly practices, Manner incentivizes customers to bring non-disposable cups by providing a discount on their purchases. The company aims to deliver delicious drinks at fair prices while addressing social responsibility through its environmental initiatives.

Clover Biopharmaceuticals

Series C in 2021
Clover Biopharmaceuticals is a clinical-stage biotechnology company based in Chengdu, China, focused on discovering and developing innovative biologic therapies for cancer, autoimmune diseases, and infectious diseases. Founded in 2007, the company utilizes its proprietary Trimer-Tag technology platform to create novel biologics that target trimerization-dependent pathways. Clover also offers integrated biopharmaceutical drug manufacturing services and has in-house capabilities for cGMP biomanufacturing, which support the development of select biosimilars. Through its research and development efforts, Clover aims to bring transformative therapies to the market.

Black Lake Technologies

Series C in 2021
Black Lake Technologies is a fast-growing and venture-backed company, revolutionizing manufacturing enterprises with mobile-, IoT- and web-based collaboration platforms that acquire, visualize, monitor and analyze real-time manufacturing data. We enable factory staff (from top management to assembly line workers) to conveniently collaborate, interpret data, extract insights, and take immediate actions. The compoany's clients range from medium-sized enterprises to Fortune 500 conglomerates, whose production is made easier by Black Lake. Its investors include GSR, BAI, GGV, ZhenFund, China Growth Capital and IDG, with over CNY 100 million funding raised to date.

pairwise, Inc.

Series B in 2021
Pairwise, Inc. is a food and technology company focused on improving the quality of fruits and vegetables through innovative agricultural gene editing techniques. Founded in 2017 and based in San Diego, California, Pairwise collaborates with food and agriculture companies to develop new crop varieties, including leafy greens, berries, and stone fruits. The company utilizes advanced tools and traits licensed from Harvard and Massachusetts General Hospital, leveraging expertise from a team with backgrounds in agriculture, consumer packaged goods, and research. With a commitment to fostering a healthier world, Pairwise aims to introduce its first products in the coming years, contributing to advancements in food technology and sustainable agriculture.

Provivi

Series C in 2020
Provivi Inc. develops biopesticides for agriculture, commercial, household, and public health pest management. It develops research quantities of carbene/nitrene transferase enzymes that activate diazo and azide compounds to generate iron-carbenoids and iron-nitrenoids through a mode of activation. The company also develops a biocatalysis and fermentation technology, which is based on biocatalysts that enable efficient synthesis of biopesticides. Its technology has applications in industries, such as pharmaceuticals, nutrition, flavors, and fragrances. The company offers its products through distributors worldwide. Provivi Inc. was incorporated in 2012 and is based in Santa Monica, California.

Locanabio

Series B in 2020
Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Form Energy

Series C in 2020
Form Energy, Inc. specializes in the development of long-duration energy storage systems aimed at replacing fossil fuel-based generation with renewable energy solutions. The company focuses on creating low-cost battery systems that can store energy from wind and solar sources for extended periods, enabling electricity supply from renewables to be more reliable and dispatchable throughout the year. Form Energy's technology, originally developed at MIT, enhances the electric grid's capacity without necessitating new transmission infrastructure and aims to diminish reliance on conventional thermal generation. Additionally, the company offers Formware, a software tool designed for capacity expansion with advanced optimization capabilities. Founded in 2017 and based in Somerville, Massachusetts, Form Energy is backed by notable investors, including Breakthrough Energy Ventures and MIT’s The Engine, and is driven by a team dedicated to overcoming complex technological challenges through innovation.

Gracell Biotechnologies

Series C in 2020
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing innovative cell therapies for cancer treatment. The company's lead product candidates include GC012F, a dual-targeted CAR-T therapy for multiple myeloma currently in Phase I trials; GC019F, which targets adult B cell acute lymphoblastic leukemia and is also in Phase I trials; and GC007F, aimed at B cell non-Hodgkin’s lymphoma, also in Phase I. Additionally, Gracell is developing GC027, a CAR-T candidate targeting adult T cell acute lymphoblastic leukemia, and GC007g, an allogeneic CAR-T therapy for relapsed or refractory B-ALL, both in Phase I trials. Beyond these, Gracell has a pipeline of earlier-stage product candidates targeting various cancers, including ovarian and breast cancer. Founded in 2017, Gracell Biotechnologies is committed to advancing cellular therapeutics to improve patient outcomes in hematological malignancies and solid tumors.

v2food

Series B in 2020
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Nuvia

Series B in 2020
Nuvia develops processors intended to create high-performance silicon design for a compute-intensive world. It designs processing chipsets for data center servers, thereby delivering a faster, power-efficient, and secure experience to existing data center processors. Manu Gulati, John Bruno, and Gerard Williams III launched Nuvia in Santa Clara, California in 2019.

TrueLayer

Series C in 2020
TrueLayer Limited is a London-based company that offers a platform for building financial applications. Established in 2016, it provides a toolkit designed to connect to bank data, verify accounts, and access transactions in real-time. TrueLayer's software-as-a-service (SaaS) platform enables the development of various consumer and small-to-medium business applications in sectors such as payments, online lending, personal financial management, robot-advisors, insurance, investment services, peer-to-peer marketplaces, and cryptocurrencies. The company's solutions are utilized by fintech startups, online lenders, and personal finance managers, contributing to the growth of the open banking economy by facilitating the creation of innovative financial services and products.

Lu Daopei Medical Group

Series B in 2020
Lu Daopei Medical Group operates hospitals in China. The company operates department of BMT, department of general hematology, lymphoma and myeloma center, and pathology and specialty hematology lab. Lu Daopei Medical Group was founded in 2002 and is based in Beijing, China.

BlueVoyant

Series C in 2020
BlueVoyant is a cybersecurity company founded in 2017 and headquartered in New York, NY. It specializes in cybersecurity defense and protection by providing a blend of technology and tailored services. The company offers advanced cyber threat intelligence and managed security services, along with proactive professional services that include forensic capabilities for incident response and remediation. BlueVoyant caters to large enterprises by delivering impactful intelligence while also making its comprehensive software and services accessible to small and medium enterprises. By leveraging a world-class team of experts, BlueVoyant enhances visibility, professional insights, and targeted responsiveness in the realm of cybersecurity, ensuring robust protective measures for its clients.

Glympse Bio

Series B in 2020
Glympse Bio, Inc. is focused on developing modular nanoparticle sensors for diagnostics in fibrosis, cancer, immunology, and infectious diseases, as well as for monitoring drug response. The company utilizes engineered diagnostic agents that assess disease states within the body and convey this information to urine for analysis. Its flagship product, Glympse Inside, serves as a pan-disease engine intended to enhance disease monitoring and treatment response. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's innovative platform technology originated at MIT and is backed by a team of experts in nanomedicine and biomedical engineering.

Perfect Day

Series C in 2020
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

JW Therapeutics

Series B in 2020
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is relmacabtagene autoleucel, an anti-CD19 CAR-T therapy for relapsed or refractory B-cell lymphoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.

Tropic Biosciences

Series B in 2020
Tropic Biosciences UK LTD is a biotechnology company focused on developing high-performing commercial varieties of tropical crops, specifically targeting the coffee and banana industries. Established in 2016 and headquartered in Norwich, United Kingdom, the company employs advanced non-GMO gene editing technologies to enhance crop performance while promoting grower wellbeing and consumer health. Through its innovative approach, Tropic Biosciences aims to improve sustainable agricultural practices and address the challenges faced by tropical crop producers.

Genor Biopharma

Series B in 2020
Genor BioPharma Co., Ltd., a biopharmaceutical company, develops and commercializes therapeutic monoclonal antibody (mAbs) and Fc-fusion protein drugs. It is developing two categories of mAb drugs, such as biosimilars and new molecular entities. The company develops products in the areas of cancer, autoimmune disease, and metabolic diseases. Genor BioPharma Co., Ltd. has a strategic collaboration with Ascentage Pharma. The company was founded in 2007 and is based in Shanghai, China. Genor BioPharma Co., Ltd. is a former subsidiary of Walvax Biotechnology Co.,Ltd.

Arterys

Series C in 2020
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Ascus Biosciences

Series B in 2020
Ascus Biosciences, founded in 2015 and headquartered in San Diego, California, focuses on developing a computational and genomics-based technology platform aimed at discovering and creating next-generation microbial products. The company's innovative approach leverages advanced data analysis and genomic insights to enhance the development of microbial solutions, catering to various applications in biotechnology and related fields.

Pivot Bio

Series C in 2020
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California. The company specializes in advancing crop nutrition through a deep understanding of the microbiome. By leveraging engineering principles and data science, Pivot Bio develops innovative solutions that utilize naturally occurring microbes to enhance crop yield and quality. Their proprietary ON Technology aims to provide essential nutrients to crops, specifically focusing on enabling microbes to fix and supply nitrogen for corn. This approach seeks to offer a sustainable alternative to traditional chemical fertilizers and pesticides, helping farmers improve their yields while addressing the nutritional needs of the growing global population. Through collaboration and communication, Pivot Bio is dedicated to transforming agricultural practices and contributing to a healthier planet.

Alan

Series C in 2020
Alan is a digital health insurance platform that revolutionizes health insurance by focusing on user experience with an excellent price-quality ratio health plan. Alan started by creating a health insurance company for individuals and companies, that they can trust as a service and enjoy as an experience. Alan is the insurance company that makes healthcare simpler, smarter, and better. It is the first new independent insurance licensed in France since 1986 by the French Prudential Supervisory Authority (ACPR) and it has raised more than €35m with leading investors such as Index Ventures, CNP, Partech, and Portage since its creation in 2016.

Abbisko Therapeutics

Series C in 2020
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

Fabric

Series B in 2020
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

Kaishu Jianggushi

Series C in 2020
Kaishuo Jianggushi is a children's content provider. Also known as Kaishu Story, the brand is focusing on children’s stories with additional products such as audio series and online parenting courses.

UPSIDE Foods

Series B in 2020
Memphis Meats develops meat produced directly from animal cells without the need to raise and slaughter actual animals that require significantly less caloric input, water, land, and energy than conventional meat production, enabling consumers to enjoy meat products that are clean and free from harmful chemicals. Founded by Uma Valeti and Nicholas Genovese in 2015, Memphis Meats is headquartered in San Francisco, California.

Soul Machines

Series B in 2020
Soul Machines Limited develops emotionally responsive avatars that augment and enrich the user experience for artificial intelligence (AI) platforms. The company’s products include Digital DNA Studio, which allows user to build custom digital people for customer care, sales and marketing, brand and influencer, product, wellbeing, people and performance, training and education, and digital innovation purposes. The company was incorporated in 2016 and is headquartered in Auckland, New Zealand with additional offices in San Francisco and Los Angeles, California; New York, New York; London, United Kingdom; Tokyo, Japan; and Melbourne, Australia.

Transcenta

Series B in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company specializing in the research, development, and manufacturing of antibody-based therapeutics. Founded in 2019 and headquartered in Suzhou, China, Transcenta has additional facilities in major cities including Shanghai, Hangzhou, and Beijing, as well as in Waltham, Massachusetts, and Princeton, New Jersey. The company was formed through the merger of HJB and MabSpace Biosciences and focuses on developing innovative antibodies aimed at treating various conditions. Currently, Transcenta is advancing nine therapeutic antibody molecules targeting oncology and select non-oncology indications, including bone and kidney disorders.

Perfect Day

Series C in 2019
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Eigen Technologies

Series B in 2019
Eigen Technologies Limited specializes in developing software for data extraction and mining, utilizing machine learning algorithms to analyze and interpret text. Founded in 2014 and headquartered in London, with an additional office in New York, the company automates the extraction and classification of information from various types of documents, enabling clients in finance, law, and professional services to make informed decisions. By employing advanced natural language processing technology, Eigen recognizes patterns within text to provide accurate answers to specific queries and classify documents based on relevant attributes. This capability allows clients to meet regulatory requirements, assess risks, and make strategic decisions regarding asset portfolios. Eigen's solutions can be deployed on-premises or in cloud environments, integrating seamlessly into existing workflows and transforming unstructured qualitative data into actionable insights.

pureLiFi

Series B in 2019
pureLiFi develops technology for communication networks that integrates data and lighting utility infrastructures. It offers a LiFi enabled a device that converts the beam of lights into an electrical signal. The signal is then converted back into data. The company was founded in 2012 and is headquartered in Edinburgh.

Bowery Farming

Series B in 2019
Bowery Farming Inc., a farming company, provides post-organic produce. The company offers baby kale, blend, lettuce, arugula, kale mix, and basil products. It sells its products through grocery stores and restaurants. The company was founded in 2014 and is based in New York, New York.